- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Biogen Idec Inc
+ Add to WatchlistBIIB:US
226.8500 USD 1.1400 0.50%As of 20:10:00 ET on 05/17/2013.
Company Profile for Biogen Idec Inc (BIIB)
Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
Contact Information
Biogen Idec Inc
133 Boston Post Rd.
Weston, MA 02493
United States
Key Executives for Biogen Idec Inc (BIIB)
| William D Young "Bill"Chairman | George A ScangosChief Executive Officer |
| Susan H AlexanderExec VP/Chief Legal Ofcr/Secy | Paul J ClancyExec VP:Finance/CFO |
| Kenneth A DipietroExec VP:Human Resources | Stephen H Holtzman "Steve"Exec VP:Corp Development |
| Stuart A Kingsley "Tony"Exec VP:Global Commercial Ops | John G CoxExec VP:Pharmaceutical |
| Douglas Edward Williams "Doug"Exec VP:Research & Dev | Claudine ProwseVP:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page